Table 1.
The clinical characteristics of 127 ESCC patients
| Variables | ESCC, n (%) |
|---|---|
| Sex | |
| Male | 80 (63.0) |
| Female | 47 (27.0) |
| Age | |
| Range (Median) | 66 (43–84) |
| Alcohol abuse | |
| Yes | 47(37) |
| No | 80 (63) |
| Smoking | |
| Yes | 61 (48) |
| No | 66 (52) |
| Location of primary tumor | |
| Upper or middle | 56 (44.1) |
| Lower | 71 (55.9) |
| Length, cm | |
| Range (Median) | 5 (2–12) |
| T stage | |
| T1–2 | 22 (17.3) |
| T3–4 | 105 (82.7) |
| Lymph node metastasis | |
| N0–1 | 105 (82.7) |
| N2–3 | 22 (17.3) |
| Metastasis | |
| M0 | 114 (89.8) |
| M1 | 13 (10.2) |
| TNM stage | |
| I–II | 31 (24.4) |
| III–IV | 96 (75.6) |
| Therapy method | |
| RT | 34 (26.8) |
| CRT | 93 (73.2) |
| RT dose (Gy) | |
| > 54 | 97 (76.4) |
| ≤ 54 | 30 (23.6) |